Skip to content
IP + Technology Law
Home  »  News & Insights  »  Presentation

Strategic Considerations for Non-Disclosure Agreements – Knobbe Practice Webinar Series

September 2, 2021  | Dan Altman and Mauricio Uribe

Partners Dan Altman and Mauricio Uribe gave an informative presentation of strategic considerations regarding non-disclosure agreements and confidentiality policies.  They provided insights related to key terms in non-disclosure agreements and best practices for negotiating non-disclosure agreements.

View live presentation: Video Link

View more webinars on our Vimeo home page: Knobbe Martens on Vimeo

View and download the full presentation below.
Knobbe Practice Webinar Series: Strategic Considerations for Non-Disclosure Agreements

View on SlideShare: Knobbe Practice Webinar Series: Strategic Considerations for Non-Disclosure Agreements

View more Knobbe Martens slide presentations here.

Strategic Considerations for Non-Disclosure Agreements – Knobbe Practice Webinar Series Headshot

Dan Altman
Partner
Orange County
dan.altman@knobbe.com
949-760-0404

Related Links

Practice Areas

News & Insights

News
Oct 2025
Knobbe Martens Maintains National Top Tier Ranking for IP Litigation Work from Benchmark Litigation
IRVINE, Calif., October 28, 2025 – Knobbe Martens is proud to share that the firm and numerous partners in its Litigation practice have been recognized in the 2026 edition of...
News
Oct 2025
Knobbe Martens Names New Chairs of Market-Leading Trademark and Brand Protection Group
IRVINE, Calif., October 22, 2025 – Knobbe Martens, one of the nation’s largest intellectual property law firms, is pleased to announce that Charlene Azema and Gregory Phillips have been named...
News
Nov 2025
Knobbe Martens Advises Pacira BioSciences in Exclusive License Agreement with AmacaThera for Novel Long-Acting Analgesic
Agreement will support the development and commercialization of non-opioid therapy for postsurgical pain control IRVINE, Calif., November 4, 2025 – A team from Knobbe Martens advised Pacira BioSciences, Inc. in...